docs/_posts/HashamUlHaq/2022-06-18-bert_token_classifier_drug_development_trials_en_3_0.md
docs/_posts/josejuanmartinez/2022-06-21-clinical_deidentification_pt_3_0.md
docs/_posts/HashamUlHaq/2022-06-18-bert_token_classifier_drug_development_trials_en_3_0.md
docs/_posts/josejuanmartinez/2022-06-21-clinical_deidentification_pt_3_0.md
